The development of platinum compounds and their possible combination.
about
Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicityUrinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugsEffect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells.Schisandrin B inhibits the proliferation of human lung adenocarcinoma A549 cells by inducing cycle arrest and apoptosis.Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin.Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.Evolving approaches to metastatic breast cancer patients pre-treated with anthracycline and taxaneEfficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.The use of X-ray absorption and synchrotron based micro-X-ray fluorescence spectroscopy to investigate anti-cancer metal compounds in vivo and in vitro.Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer.Role of PAR2 in regulating oxaliplatin-induced neuropathic pain via TRPA1Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers.New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation.Urinary TIMP2⋅IGFBP7 for the prediction of platinum-induced acute renal injury.Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration.A relativistic DFT methodology for calculating the structures and NMR chemical shifts of octahedral platinum and iridium complexes.Neurotoxic Effects of Platinum Compounds: Studies in vivo on Intracellular Calcium Homeostasis in the Immature Central Nervous System.Renoprotective effects of antioxidants against cisplatin nephrotoxicity.
P2860
Q24655188-72DB76AF-4AD4-4A95-867A-C5FE31A0C4C2Q28388226-AB1857F1-2ED2-42EE-8834-E993768C8033Q35307690-76885609-1364-448E-A2EE-9E65C35C9CAEQ35870634-2987D25B-2964-41FE-B392-4A27A077090BQ36500869-A0396B5E-2659-4CC8-AE1B-5D08308C1EB4Q36557513-6FE356D2-0183-40E0-A999-99B90870247AQ37177111-035589AA-A62D-419F-9AEA-F3626B36D3A0Q37338244-375BAD13-F914-42C8-82B5-8C64B50582B7Q38096196-4B47F98D-FAF7-4B02-8ED2-15B32308B141Q38288535-6F4CF72E-0595-4ED3-8584-548363974D32Q38325864-E514DC5B-0FC0-4E5F-BE83-A0F07BB2C154Q38998496-D5347E4B-322B-411A-A897-501FFD59551AQ39258510-8E80985F-3992-4F3D-BB6D-F7BFEC0D384BQ39321451-3BA65589-C270-4A07-9AC0-8E8D7FCB5503Q40954510-90C86653-875F-495C-9F31-C2DB6D19CD6DQ41680103-440B2F4D-8B9B-495A-9DAB-48BA64482FB4Q43655859-C09B0F87-182D-456E-BE83-58382F291C0FQ47724377-38DAC79E-3DB5-4F79-A550-02F9788B83FBQ51137792-F93D77F9-711E-4D90-AF6F-C0FAB5A47F51
P2860
The development of platinum compounds and their possible combination.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The development of platinum compounds and their possible combination.
@ast
The development of platinum compounds and their possible combination.
@en
type
label
The development of platinum compounds and their possible combination.
@ast
The development of platinum compounds and their possible combination.
@en
prefLabel
The development of platinum compounds and their possible combination.
@ast
The development of platinum compounds and their possible combination.
@en
P2093
P1476
The development of platinum compounds and their possible combination.
@en
P2093
Elena Rossi
Lara Maria Pasetto
Mario Rosario D'Andrea
P356
10.1016/J.CRITREVONC.2006.02.003
P577
2006-06-27T00:00:00Z